Australia’s only locally manufactured QIV now TGA approved – August 2, 2016

Australia’s only locally manufactured, quadrivalent seasonal influenza vaccine (QIV) received Therapeutic Goods Administration (TGA) approval on July 15, 2016.  Afluria Quad™, Seqirus’ four-strain, inactivated seasonal influenza vaccine, is indicated for people aged 18 years and older.1 The new quadrivalent vaccine will replace the company’s trivalent vaccine (TIV), Fluvax® for the 2017 flu season.  Manufactured by…

Read More

VIVA! Communications & GLOBALHealthPR pledge their support for World Hepatitis Day – July 28, 2016

VIVA! Communications and GLOBALHealthPR are proud to announce their official support for World Hepatitis Day, July 28, 2016, joining a plethora of organisations that are fighting to ELIMINATE chronic Hepatitis C. World Hepatitis Day unites people from all walks of life to raise awareness of the substantial global burden of viral hepatitis and to provoke…

Read More

The future of medicine is not a ‘one-size-fits-all’ – July 8, 2016

Research and Markets, a world-renowned market research report hub, recently released their new Global DNA Sequencing Products Market 2016-2020 report that identified personalised medicine and global DNA sequencing products as the next big trend in medical rese arch. According to the report, DNA sequencing technology can be applied in diagnostics, drug and biomarker discovery, agriculture,…

Read More

VIC pharmacies now permitted to administer flu shots – July 7, 2016

Victoria has fallen into line with the rest of Australia, permitting community pharmacies to administer flu shots. In May, 2016, the Victorian branches of the Pharmaceutical Society of Australia (PSA) and the Pharmacy Guild of Australia, publicly welcomed the Victorian Government’s approval for National Immunisation Program (NIP)-funded flu vaccines to be administered in pharmacy. A…

Read More